Karuna Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR TREATING DISORDERS AMELIORATED BY MUSCARINIC RECEPTOR ACTIVATION
Last updated:
Abstract:
Provided herein is an oral pharmaceutical composition, comprising a plurality of xanomeline beads having a core comprising xanomeline or a salt thereof; and a plurality of trospium beads having a core comprising a salt of trospium.
Status:
Application
Type:
Utility
Filling date:
7 Jan 2021
Issue date:
17 Jun 2021